Search

Author/Creator Steinberg, Seth M.

31. Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front‐line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125. Issue 21 (2nd July 2014)

Authors:
Hassan, Raffit; Sharon, Elad; Thomas, Anish; Zhang, Jingli; Ling, Alexander; Miettinen, Markku; Kreitman, Robert J.; Steinberg, Seth M.; Hollevoet, Kevin; Pastan, Ira
Journal:
Cancer
Issue:
Volume 120:Issue 21(2014)
Page Start:
3311
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin. Issue 22 (1st September 2020)

Authors:
Hassan, Raffit; Alewine, Christine; Mian, Idrees; Spreafico, Anna; Siu, Lillian L.; Gomez‐Roca, Carlos; Delord, Jean‐Pierre; Italiano, Antoine; Lassen, Ulrik; Soria, Jean‐Charles; Bahleda, Rastilav; Thomas, Anish; Steinberg, Seth M.; Peer, Cody J.; Figg, William D.; Niederfellner, Gerhard; Méress...
Journal:
Cancer
Issue:
Volume 126:Issue 22(2020)
Page Start:
4936
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas. Issue 8 (3rd July 2019)

Authors:
Roswarski, Joseph; Roschewski, Mark; Melani, Christopher; Pittaluga, Stefania; Lucas, Andrea; Steinberg, Seth M.; Jaffe, Elaine S.; Waldmann, Thomas A.; Wilson, Wyndham H.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 8(2019)
Page Start:
2062
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Issue 5 (4th February 2014)

Authors:
Widemann, Brigitte C.; Dombi, Eva; Gillespie, Andrea; Wolters, Pamela L.; Belasco, Jean; Goldman, Stewart; Korf, Bruce R.; Solomon, Jeffrey; Martin, Staci; Salzer, Wanda; Fox, Elizabeth; Patronas, Nicholas; Kieran, Mark W.; Perentesis, John P.; Reddy, Alyssa; Wright, John J.; Kim, AeRang; Steinbe...
Journal:
Neuro-oncology
Issue:
Volume 16:Issue 5(2014:May)
Page Start:
707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Issue 6 (3rd June 2018)

Authors:
Roswarski, Joseph; Roschewski, Mark; Lucas, Andrea; Melani, Christopher; Pittaluga, Stefania; Jaffe, Elaine S.; Steinberg, Seth M.; Waldmann, Thomas A.; Wilson, Wyndham H.
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 6(2018)
Page Start:
1466
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

36. Phase II clinical trial of cediranib in patients with metastatic castration‐resistant prostate cancer. (18th February 2013)

Authors:
Dahut, William L.; Madan, Ravi A.; Karakunnel, Joyson J.; Adelberg, David; Gulley, James L.; Turkbey, Ismail B.; Chau, Cindy H.; Spencer, Shawn D.; Mulquin, Marcia; Wright, John; Parnes, Howard L.; Steinberg, Seth M.; Choyke, Peter L.; Figg, William D.
Journal:
BJU international
Issue:
Volume 111:Number 8(2013:Apr.)
Page Start:
1269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer. (19th February 2016)

Authors:
Madan, Ravi A.; Karzai, Fatima H.; Ning, Yang‐Min; Adesunloye, Bamidele A.; Huang, Xuan; Harold, Nancy; Couvillon, Anna; Chun, Guinevere; Cordes, Lisa; Sissung, Tristan; Beedie, Shaunna L.; Dawson, Nancy A.; Theoret, Marc R.; McLeod, David G.; Rosner, Inger; Trepel, Jane B.; Lee, Min‐Jung; Tomita...
Journal:
BJU international
Issue:
Volume 118:Number 4(2016:Aug.)
Page Start:
590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Issue 9 (22nd April 2014)

Authors:
Widemann, Brigitte C.; Babovic‐Vuksanovic, Dusica; Dombi, Eva; Wolters, Pamela L.; Goldman, Stewart; Martin, Staci; Goodwin, Anne; Goodspeed, Wendy; Kieran, Mark W.; Cohen, Bruce; Blaney, Susan M.; King, Allison; Solomon, Jeffrey; Patronas, Nicholas; Balis, Frank M.; Fox, Elizabeth; Steinberg, Se...
Journal:
Pediatric blood & cancer
Issue:
Volume 61:Issue 9(2014:Sep.)
Page Start:
1598
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. Prevalence of Isolated Joint Involvement in Chronic Graft‐Versus‐Host Disease: Comment on the Article by Inamoto et al. Issue 9 (September 2014)

Authors:
Kuzmina, Zoya; Joe, Galen O.; Baird, Kristin; Cowen, Edward W.; Naik, Haley B.; Steinberg, Seth M.; Curtis, Lauren; Comis, Leora E.; Pavletic, Steven Z.
Journal:
Arthritis & rheumatology
Issue:
Volume 66:Issue 9(2014)
Page Start:
2646
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗